exhibit 10. 1statement of workforclinical trial supportthis statement of work ( “ sow ” ) is entered into on july 26, 2021, pursuant to a master services agreement dated april 1, 2020, ( the “ msa ” ) between neurorx, inc., now a wholly - owned subsidiary of nrx pharmaceuticals, inc. ( “ nrx ” ), and pilltracker ltd. ( “ pilltracker ” ) the terms and conditions of the msa are incorporated into this statement of work by reference. the scope of work outlined below is focused on support of inhaled zyesami in phase 2 / 3 clinical trials by monitoring patients in a sub - study of the avicovid - 2 clinical trial, in which pilltracker will continuously monitor sp02 and heart rate to determine the physiological effects of drug vs placebo. it includes pre - trial setup and deployment of pilltracker ’ s platform and devices, ongoing service and support to the avicovid - 2 clinical trial, and any necessary sourcing, logistics and distribution requirements needed to successfully support inhaled zyesami. this study is currently intended to take place in the united states at pre - enrolled sites that are already participating in the study. all costs detailed below are estimates based on supporting a study in u. s., and do not include additional deployments to other countries. the total project is scoped at 625 hours, and is divided into two phasese ( a ) pre - development and ( b ) implementation phases as follows : 1. pre - trial setup : the pilltracker development team will scout, procure, integrate and deploy an iot suite for the purposes of supporting the patient - use of inhaled zyesami in clinical trials. this includes setup of a mobile device management system, setup of a help - desk, software development and deployment configuration ( dev - ops ), and other pre - launch costs. if, during the setup phase, more than [ 10 ] hours of addition software development is required to adapt the software platform for the study, pilltracker will provide such development in excess of [ 10 ] hours on a time - and - materials basis at the following rates : ●a blended rate of $ 72 / hour for general development, and● $ 160 / hour for the time of a chief technology officer or senior software architect. with such additional development work to be subject to a budget agreed in writing with nrx.